Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >


Add MRSN Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 10/3/2017 7:44:17 PM - Followers: 3 - Board type: Free - Posts Today: 0

Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is based in Cambridge, Massachusetts.
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
MRSN News: Mersana Appoints Lawrence M. Alleva to Board of Directors 09/05/2017 04:05:00 PM
MRSN News: Mersana Therapeutics to Participate in Investor Conferences in September 08/31/2017 07:00:00 AM
MRSN News: Mersana Announces Second Quarter 2017 Financial Results and Provides Business Updates 08/11/2017 07:00:00 AM
MRSN News: Mersana Therapeutics to Present at Wedbush PacGrow Healthcare Conference 08/09/2017 10:28:00 AM